SequelSEC

COLLEGIUM PHARMACEUTICAL, INC COLL

Pharmaceutical Preparations · CIK 0001267565 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$808.21M
Fiscal year ended 2026-06-30
Operating income
$157.44M
Fiscal year ended 2026-06-30
Free cash flow
$328.28M
Fiscal year ended 2026-06-30

COLLEGIUM PHARMACEUTICAL, INC (COLL) reported revenue of $808.21M and net income of $47.92M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from COLLEGIUM PHARMACEUTICAL, INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

COLLEGIUM PHARMACEUTICAL, INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$808.21M
Cost of revenue$323.12M
Gross profit$485.09M
Operating income$157.44M
Net income$47.92M
Research & developmentUnavailable
Weighted-average diluted sharesshares 152.04M
Pretax income$77.68M
Income tax expense$29.76M
Diluted EPS$1.24
Selling, general & administrative$327.69M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

COLLEGIUM PHARMACEUTICAL, INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$129.47M
Total assets$2.14B
Current assets$608.01M
Total liabilities$1.82B
Current liabilities$589.86M
Total equity incl. NCI$311.91M
Temporary (mezzanine) equityUnavailable
Inventory$113.27M
Accounts receivable$285.10M
Goodwill$190.18M
Long-term debtUnavailable
Accounts payable$9.24M

Cash flow

COLLEGIUM PHARMACEUTICAL, INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$329.92M
Capital expenditures$1.64M
Investing cash flow-$551.90M
Financing cash flow$234.11M
Net change in cashUnavailable
Stock-based compensation$44.93M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

COLLEGIUM PHARMACEUTICAL, INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$328.28M
Gross margin60.0%
Operating margin19.5%
FCF margin40.6%
SBC / revenue5.6%
Current ratio1.03x
Revenue YoY growth14.3%
Net margin5.9%
R&D / revenueUnavailable
CapEx / revenue0.2%
Long-term debt / equityUnavailable
Effective tax rate38.3%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open COLL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.